Cencora, Inc. · NYSE:COR
Cencora — 44th Annual J.P. Morgan Healthcare Conference (January 2026)
13 slides from Cencora's conference presentation, Jan 12, 2026
Slide 1: J.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference Bob Mauch, President and Chief Executive Officer JANUARY 12, 2026
Slide 2: Cautionary note regarding forward-looking statements
Cautionary note regarding forward-looking statements Certain of the statements contained in this presentation are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Securit
Slide 3: Creating healthier futures: Cencora at a glance
Creating healthier futures: Cencora at a glance A leading global pharmaceutical solutions organization 1B+ #1 140 51,000+ Medications shipped Retina research Specialty logistics Purpose-driven annually network and 3PL sites team members globally $321B $4.2B $16.00 $3.0B +9% y-o-y +16% y-o-y +16% y-o
Slide 4: Our strategic vision: Creating differentiated value for our stakeholders
Our strategic vision Creating differentiated value for our stakeholders Growth Priorities Strategic Drivers Lead Strengthen our Catalyze Prioritize with market Position in specialty customer-centricity with growth-oriented leaders pharmaceuticals data & technology investments Enhance patient Foster
Slide 5: Our progress: Recent highlights
Our progress Recent highlights Informed by our strategic drivers and guided by our growth priorities Completed acquisition of Retina Consultants of America Announced intent to accelerate acquisition of OneOncology Announced plans to invest $1 billion in supply chain infrastructure through 2030 Expan
Slide 6: Our growth platform: U.S. Healthcare Solutions segment
GROWTH DRIVERS Our growth platform U.S. Healthcare Solutions segment • Long-term strategic relationships Foundational with market-leading customers in each channel pharmaceutical distribution • Specialty distribution and services contribute to our value Leadership in specialty as a partner of choice
Slide 7: Our growth priorities: Specialty - Extending specialty solutions through MSOs
Our growth priorities: Specialty Extending specialty solutions through MSOs Streamlines back-office operations allowing providers to focus on patient care Expands access to innovative treatments and clinical trials for patients in local communities Strengthens partnerships with pharma through data,
Slide 8: Our growth platform: International Healthcare Solutions segment
GROWTH DRIVERS Our growth platform International Healthcare Solutions segment • Leading pan-European wholesaler with downstream services Pan-European to support partners pharmaceutical distribution • Premier global specialty logistics provider, supporting Global specialty and clinical trials and del
Slide 9: Building on track record of driving long-term stakeholder value
Our value Building on track record of driving long-term stakeholder value STRONG FOUNDATION ENHANCING VALUE PROP DRIVING RETURNS Longstanding healthcare Investing to advance Generating strong free- solutions partner pharmaceutical-centric cash flow strategy Industry driven by Maintaining high return
Slide 10: Appendix
Appendix 10
Slide 11: GAAP to Non-GAAP reconciliations
GAAP to Non-GAAP reconciliations In thousands except per share data Fiscal Year Ended September 30, 2025 Income Net Income Diluted Operating Operating Before Income Tax Attributable Earnings Gross Profit Expenses Income Taxes Expense to Cencora per Share GAAP $11,478,539 $8,849,938 $2,628,601 $2,258
Slide 12: Adjusted free cash flow reconciliation – Fiscal Year Ended September 30, 2025
Adjusted free cash flow reconciliation – Fiscal Year Ended September 30, 2025 In thousands Operating Cash Flows $3,875,120 Capital expenditures (667,981) Gains from antitrust litigation settlements (236,372) Adjusted Free Cash Flow $2,970,767 12
Slide 13: Contact
Contact Bennett S. Murphy Senior Vice President Investor Relations and Enterprise Productivity Bennett.Murphy@cencora.com 13
Cencora — 44th Annual J.P. Morgan Healthcare Conference (January 2026) on 6ix